A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.
Clinical trial NCT00046696 · COMPLETED
Trial details
- NCT number
- NCT00046696
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2006-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.